Generation Bio (GBIO)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	23.81 mm	23.81 mm	23.81 mm	23.81 mm	23.81 mm	23.81 mm
Cash burn (monthly)	5.35 mm	10.57 mm	5.96 mm	13.77 mm	5.10 mm	8.07 mm
Cash used (since last report)	14.99 mm	29.62 mm	16.70 mm	38.59 mm	14.30 mm	22.62 mm
Cash remaining	8.82 mm	-5.81 mm	7.11 mm	-14.78 mm	9.51 mm	1.19 mm
Runway (months of cash)	1.6	-0.5	1.2	-1.1	1.9	0.1

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

GBIO institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	84	70	+20.0%
Opened positions	21	58	-63.8%
Closed positions	7	1	+600.0%
Increased positions	26	3	+766.7%
Reduced positions	21	2	+950.0%

13F shares	Current	Prev Q	Change
Total value	127.96 bn	129.36 bn	-1.1%
Total shares	76.03 mm	62.48 mm	+21.7%
Total puts	200.00	0.00	NEW
Total calls	100.00	12.40 k	-99.2%
Total put/call ratio	2.0	–	–

Largest owners	Shares	Value	Change
T. Rowe Price	9.51 mm	$26.83 mm	+7.2%
Atlas Venture Life Science Advisors	8.28 mm	$23.35 bn	NEW
Atlas Venture Fund X	7.11 mm	$50.35 mm	0.0%
ModernaTX	5.86 mm	$0.00	0.0%
FMR	5.30 mm	$14.96 bn	-0.6%
BLVGF Bellevue	3.92 mm	$11.05 bn	+1.5%
BBBOF BB Biotech	3.61 mm	$0.00	0.0%
BLK BlackRock	3.29 mm	$9.29 bn	+8.0%
BAC Bank of America	2.98 mm	$8.41 bn	NEW
Artal	2.83 mm	$7.98 bn	0.0%

Largest transactions	Shares	Bought/sold	Change
Atlas Venture Life Science Advisors	8.28 mm	+8.28 mm	NEW
BAC Bank of America	2.98 mm	+2.98 mm	NEW
Baker Bros. Advisors	1.21 mm	+1.21 mm	NEW
Partner Fund Management	787.91 k	-834.57 k	-51.4%
Deutsche Bank AG - Registered Shares	558.00 k	-693.57 k	-55.4%
T. Rowe Price	9.51 mm	+635.27 k	+7.2%
D. E. Shaw & Co.	487.54 k	+487.54 k	NEW
Charles Schwab Investment Management	414.61 k	+414.61 k	NEW
Jacobs Levy Equity Management	301.05 k	+301.05 k	NEW
BLK BlackRock	3.29 mm	+245.40 k	+8.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

GBIO insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
15 Oct 24	Mcdonough Geoff	Common Stock	Payment of exercise	Dispose F	No	No	2.42	1,548	3.75 k	1,337,629
15 Oct 24	Mcdonough Geoff	Common Stock	Option exercise	Acquire M	No	No	0	5,274	0.00	1,339,177
15 Oct 24	Mcdonough Geoff	RSU Common Stock	Option exercise	Dispose M	No	No	0	5,274	0.00	47,459
15 Oct 24	Matthew Norkunas	Common Stock	Payment of exercise	Dispose F	No	No	2.42	492	1.19 k	57,348
15 Oct 24	Matthew Norkunas	Common Stock	Option exercise	Acquire M	No	No	0	1,673	0.00	57,840
15 Oct 24	Matthew Norkunas	Common Stock	Payment of exercise	Dispose F	No	No	2.42	492	1.19 k	56,167
15 Oct 24	Matthew Norkunas	Common Stock	Option exercise	Acquire M	No	No	0	1,674	0.00	56,659
15 Oct 24	Matthew Norkunas	RSU Common Stock	Option exercise	Dispose M	No	No	0	1,673	0.00	1,673
15 Oct 24	Matthew Norkunas	RSU Common Stock	Option exercise	Dispose M	No	No	0	1,674	0.00	15,059
15 Oct 24	Phillip Samayoa	Common Stock	Payment of exercise	Dispose F	No	No	2.42	337	815.54	122,097

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

Generation Bio Q3 EPS $(0.23) Beats $(0.28) Estimate, Sales $7.55M Beat $1.88M Estimate

6 Nov 24

Generation Bio (NASDAQ:GBIO) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.28) by 17.86 percent. This is a 46.51 percent increase over losses of $(0.43) per share from

Needham Reiterates Buy on Generation Bio, Maintains $10 Price Target

23 Oct 24

Needham analyst Gil Blum reiterates Generation Bio (NASDAQ:GBIO) with a Buy and maintains $10 price target.